Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or OpenAthens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Commentary

Free Access

A Review of the Use of Fine-Needle Aspiration Biopsy of Mammary Tumors for Diagnosis and Research

Tani E. · Fuentes-Martinez N. · Skoog L.

Author affiliations

Department of Pathology and Cytology, Karolinska University Hospital Solna, Stockholm, Sweden

Corresponding Author

Correspondence to: Dr. Nelson Fuentes-Martinez

Department of Pathology and Cytology

Karolinska University Hospital Solna

SE-171 76 Stockholm (Sweden)

E-Mail nelson.fuentes-martinez@sll.se

Related Articles for ""

Acta Cytologica 2017;61:305-315

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



Abstract

The article “Aspiration Biopsy of Mammary Tumors in Diagnosis and Research - A Critical Review of 2,200 Cases” by Zajicek et al. [Acta Cytol 1967;11:169-175] is composed of two separate parts as can be seen from the title. Both are, however, of great historical interest. The first describes the early days of fine-needle aspiration cytology diagnosis of breast lesions in particular carcinomas. The results are still impressive with a diagnostic accuracy close to 90%. The second deals with the effect of negative pressure on cell viability during the aspiration procedure. These studies were aimed at evaluating the usefulness of aspirated tumor cells to analyze the effects of therapy and the origin of tumor cells.

© 2017 S. Karger AG, Basel


References

  1. Zajicek J, Franzén S, Jakobsson P, Rubio C, Unsgaard B: Aspiration biopsy of mammary tumors in diagnosis and research - a critical review of 2,200 cases. Acta Cytol 1967;11:169-175.
    External Resources
  2. Franzén S, Zajicek J: Aspiration biopsy in diagnosis of palpable lesions of the breast. Critical review of 3,479 consecutive biopsies. Acta Radiol Ther Phys Biol 1968;7:241-262.
  3. Zajicek J: Cytologic study of punctates in mammary gland diagnosis (in German). Schweiz Med Wochenschr 1969;99:1271-1273.
    External Resources
  4. Kreuzer G, Zajicek J: Cytologic diagnosis of mammary tumors from aspiration biopsy smears. Acta Cytol 1972;16:249-252.
    External Resources
  5. Löfgren L, Skoog L, von Schoultz, Tani E, Isaksson E, Fernstad R, Carlström K, von Schoultz B: Hormone receptor status in breast cancer - a comparison between surgical specimens and fine needle aspiration biopsies. Cytopathology 2003;14:136-142.
  6. Masood S: Assessment of prognostic factors in breast fine needle aspirates. Am J Clin Pathol 200;113(5 suppl 1):584-596.
    External Resources
  7. Zajicek J: Sampling of cells from human tumors by aspiration biopsy for diagnosis and research. Eur J Cancer 1965;1:253-258.
  8. Esposti PL, Estborn B, Zajicek J: Determination of acid phosphatase activity in cells of prostatic tumours. Nature 1960;188:663-664.
  9. Nordenskjöld B, Löwhagen T, Westerberg H, Zajicek J: 3H-Thymidine incorporation into mammary carcinoma cells obtained by needle aspiration before and during endocrine therapy. Acta Cytol 1976;20:137-143.
    External Resources
  10. Azavedo E, Baral E, Skoog L: Immunohistochemical analysis in cells obtained by fine needle aspiration from human mammary carcinomas. Anticancer Res 1986;6:263-266.
    External Resources
  11. Tani EM, Christensson B, Porwit A, Skoog L: Immunocytochemical analysis and cytomorphological diagnosis on fine needle aspirates of lymphoproliferative diseases. Acta Cytol 1988;32:209-215.
    External Resources
  12. Skoog L, Rutqvist LE, Wilking N: Analysis of hormone receptors and proliferation fraction in fine-needle aspirates from primary breast carcinomas during chemotherapy or tamoxifen treatment. Acta Oncol 1992;31:139-141.
  13. Billgren A-M, Rutquist LE, Tani E, Wilking N, Fornander T, Skoog L: Proliferating fraction during neo adjuvant chemotherapy of primary breast cancer in relation to objective local response and relapse-free survival. Acta Oncol 1999;38:597-601.

Article / Publication Details

First-Page Preview
Abstract of Commentary

Received: May 03, 2017
Accepted: May 09, 2017
Published online: July 11, 2017
Issue release date: July – October

Number of Print Pages: 11
Number of Figures: 0
Number of Tables: 0

ISSN: 0001-5547 (Print)
eISSN: 1938-2650 (Online)

For additional information: https://www.karger.com/ACY

References

  1. Zajicek J, Franzén S, Jakobsson P, Rubio C, Unsgaard B: Aspiration biopsy of mammary tumors in diagnosis and research - a critical review of 2,200 cases. Acta Cytol 1967;11:169-175.
    External Resources
  2. Franzén S, Zajicek J: Aspiration biopsy in diagnosis of palpable lesions of the breast. Critical review of 3,479 consecutive biopsies. Acta Radiol Ther Phys Biol 1968;7:241-262.
  3. Zajicek J: Cytologic study of punctates in mammary gland diagnosis (in German). Schweiz Med Wochenschr 1969;99:1271-1273.
    External Resources
  4. Kreuzer G, Zajicek J: Cytologic diagnosis of mammary tumors from aspiration biopsy smears. Acta Cytol 1972;16:249-252.
    External Resources
  5. Löfgren L, Skoog L, von Schoultz, Tani E, Isaksson E, Fernstad R, Carlström K, von Schoultz B: Hormone receptor status in breast cancer - a comparison between surgical specimens and fine needle aspiration biopsies. Cytopathology 2003;14:136-142.
  6. Masood S: Assessment of prognostic factors in breast fine needle aspirates. Am J Clin Pathol 200;113(5 suppl 1):584-596.
    External Resources
  7. Zajicek J: Sampling of cells from human tumors by aspiration biopsy for diagnosis and research. Eur J Cancer 1965;1:253-258.
  8. Esposti PL, Estborn B, Zajicek J: Determination of acid phosphatase activity in cells of prostatic tumours. Nature 1960;188:663-664.
  9. Nordenskjöld B, Löwhagen T, Westerberg H, Zajicek J: 3H-Thymidine incorporation into mammary carcinoma cells obtained by needle aspiration before and during endocrine therapy. Acta Cytol 1976;20:137-143.
    External Resources
  10. Azavedo E, Baral E, Skoog L: Immunohistochemical analysis in cells obtained by fine needle aspiration from human mammary carcinomas. Anticancer Res 1986;6:263-266.
    External Resources
  11. Tani EM, Christensson B, Porwit A, Skoog L: Immunocytochemical analysis and cytomorphological diagnosis on fine needle aspirates of lymphoproliferative diseases. Acta Cytol 1988;32:209-215.
    External Resources
  12. Skoog L, Rutqvist LE, Wilking N: Analysis of hormone receptors and proliferation fraction in fine-needle aspirates from primary breast carcinomas during chemotherapy or tamoxifen treatment. Acta Oncol 1992;31:139-141.
  13. Billgren A-M, Rutquist LE, Tani E, Wilking N, Fornander T, Skoog L: Proliferating fraction during neo adjuvant chemotherapy of primary breast cancer in relation to objective local response and relapse-free survival. Acta Oncol 1999;38:597-601.

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.